Logo image

Cancer treatment with dendritic cell-based cancer vaccine

Cancer treatment with dendritic cell-based cancer vaccine
1
Media Files
1

Overview

Type of care

Outpatient

Method

Non-surgical

About the offer

Dendritic cell-based cancer vaccines are a type of immunotherapy in which the patient's dendritic cells are used to make the immune system attack cancer cells. Dendritic cells are significant to the immune response because they show foreign substances to T cells, white blood cells crucial to the immune reaction. In making a vaccine, dendritic cells from the patient's blood or bone marrow are taken and put in a lab where they are exposed to cancer antigens. The dendritic cells are then given back to the patient, where they can help the immune system fight cancer cells. Each patient's dendritic cells are used to make a dendritic cell-based cancer vaccine, so each vaccine is unique. Dendritic cell-based cancer vaccines may target and kill cancer cells. They use dendritic cells to make the immune system attack cancer cells. Since vaccines are made from the patient's cells, they may have fewer side effects than other cancer treatments. Cancer vaccines made from dendritic cells might cause the immune system to respond to cancer cells in a way that lasts for a long time. It could make it less likely that cancer will come back. Dendritic cell-based cancer vaccines are still experimental and studied in clinical trials.

What’s included

Medical service

Examination
  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with an oncologist
  • consultation with an immunologist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests, electrolytes)
  • inflammation blood tests
Diagnosis
  • ultrasound imaging
  • CT/MRI scan
  • fine needle aspiration biopsy of the tumor
  • histopathological specimen examination
  • immunohistochemistry test (IHC)
Treatment
  • pre-procedure patient preparation
  • autologous dendritic cell harvesting
  • dendritic cells incubation and activation
  • infusion of mature dendritic cells
  • post-procedure care
  • symptomatic treatment
Other
  • cost of the drug production
  • cost of essential medicines
  • cost of essential materials
  • nursing service
  • discharge medical records
  • further recommendations

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

FAQ

What is the cost?

The total price for Cancer treatment with dendritic cell-based cancer vaccine is €25,891. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

How long does the offer take?

The offer is designed for 28 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Individual cost estimate. Non-binding 100% free assessment.

€25,891

Similar deals